Patents by Inventor Eric S. Burak

Eric S. Burak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220265636
    Abstract: The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
    Type: Application
    Filed: August 18, 2021
    Publication date: August 25, 2022
    Inventors: Danping LI, Eric S. BURAK, David S. DRESBACK, Danielle B. LORD
  • Publication number: 20210395281
    Abstract: The present disclosure relates to macrocyclic chelates including a macrocyclic chelating moiety of a metal complex thereof, a bifunctional linker, and a therapeutic or targeting moiety. Also disclosed are methods for preparation of the same, and use thereof.
    Type: Application
    Filed: January 8, 2021
    Publication date: December 23, 2021
    Inventors: Stuart J. Mahoney, Michael B. Johansen, Matthew D. Moran, Melissa Chassé, Ryan W. Simms, Eric S. Burak, John F. Valliant
  • Publication number: 20200022971
    Abstract: The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
    Type: Application
    Filed: May 29, 2019
    Publication date: January 23, 2020
    Inventors: Danping LI, Eric S. BURAK, David S. DRESBACK, Danielle B. LORD
  • Publication number: 20160235736
    Abstract: The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
    Type: Application
    Filed: February 12, 2016
    Publication date: August 18, 2016
    Inventors: Danping LI, Eric S. BURAK, David S. DRESBACK, Danielle B. LORD
  • Patent number: 9409896
    Abstract: The present invention relates to carrier systems useful for pharmaceutical compositions. These carriers comprise an emulsifier, and also in further embodiments a polymeric dissolution aid. These carriers are useful for delivering pharmaceutical actives such as antimicrobial agents.
    Type: Grant
    Filed: November 1, 2011
    Date of Patent: August 9, 2016
    Assignee: Melinta Therapeutics, Inc.
    Inventors: Eric S. Burak, Danping Li, David S. Dresback
  • Publication number: 20150165040
    Abstract: The present invention relates to pharmaceutical compositions useful for administration for treating, preventing, or reducing the risk of microbial infections.
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Inventors: Eric S. Burak, Danping Li
  • Publication number: 20140094463
    Abstract: The present invention relates to carrier systems useful for pharmaceutical compositions. These carriers comprise an emulsifier, and also in further embodiments a polymeric dissolution aid. These carriers are useful for delivering pharmaceutical actives such as antimicrobial agents.
    Type: Application
    Filed: November 1, 2011
    Publication date: April 3, 2014
    Applicant: RIB-X PHARMACEUTICALS, INC.
    Inventors: Eric S. Burak, Danping Li, David S. Dresback
  • Publication number: 20120208857
    Abstract: The present invention relates to pharmaceutical compositions useful for administration for treating, preventing, or reducing the risk of microbial infections.
    Type: Application
    Filed: October 12, 2010
    Publication date: August 16, 2012
    Inventors: Eric S. Burak, Danping Li
  • Publication number: 20120065186
    Abstract: The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
    Type: Application
    Filed: May 11, 2011
    Publication date: March 15, 2012
    Inventors: Danping LI, Eric S. BURAK, David S. DRESBACK, Danielle B. LORD
  • Patent number: 6486151
    Abstract: This invention relates to neurotrophic low molecular weight, small molecule N-oxides of heterocyclic esters amides, thioesters, and ketones having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
    Type: Grant
    Filed: April 26, 2001
    Date of Patent: November 26, 2002
    Assignee: GPI NIL Holdings Inc.
    Inventors: Gregory S. Hamilton, Joseph P. Steiner, Eric S. Burak
  • Publication number: 20010036942
    Abstract: This invention relates to neurotrophic low molecular weight, small molecule N-oxides of heterocyclic esters amides, thioesters, and ketones having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
    Type: Application
    Filed: April 26, 2001
    Publication date: November 1, 2001
    Inventors: Gregory S. Hamilton, Joseph P. Steiner, Eric S. Burak
  • Patent number: 6251892
    Abstract: This invention relates to neurotrophic low molecular weight, small molecule N-oxides of heterocyclic esters, amides, thioesters, and ketones having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
    Type: Grant
    Filed: April 21, 2000
    Date of Patent: June 26, 2001
    Assignee: GPI NIL Holdings, Inc.
    Inventors: Gregory S. Hamilton, Joseph P. Steiner, Eric S. Burak
  • Patent number: 6054452
    Abstract: This invention relates to neurotrophic low molecular weight, small molecule N-oxides of heterocyclic esters, amides, thioesters, and ketones having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
    Type: Grant
    Filed: July 9, 1998
    Date of Patent: April 25, 2000
    Assignee: GPI NIL Holdings, Inc.
    Inventors: Gregory S. Hamilton, Joseph P. Steiner, Eric S. Burak
  • Patent number: 5846979
    Abstract: This invention relates to neurotrophic low molecular weight, small molecule N-oxides of heterocyclic esters, amides, thioesters, and ketones having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: December 8, 1998
    Assignee: GPI NIL Holdings, Inc.
    Inventors: Gregory S. Hamilton, Joseph P. Steiner, Eric S. Burak